Home » Topics » Disease categories and therapies » Immune

Immune
RSS

American Biogenetic Sciences enters agreement for anthrax and smallpox vaccines

Nov. 27, 2001

Recombinant HSP-based vaccine enters clinical testing at Antigenics for infectious disease

Nov. 27, 2001

Celgene and Cornell extend thalidomide/IMiD research partnership

Nov. 23, 2001

Phase II results of multigene DNA vaccine against malaria

Nov. 15, 2001

BioSante licenses vaccine technology to Corixa

Nov. 14, 2001

AMD-3100 rapidly mobilizes stem cells in phase I trial

Nov. 12, 2001

Quest Diagnostics, exclusive distributor of Vasogen's immune modulation therapy

Nov. 12, 2001

Wyeth Lederle Vaccines and RIVM collaborate on meningitis vaccine development

Nov. 12, 2001

Aventis prepares beta-carboline inhibitor of IKK which prolongs cardiac graft survival

Nov. 9, 2001

Vaccines for chronic diseases jointly researched by Novartis and Cytos

Nov. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...